About Us      General Prenatal Care      Specific Substances      Perinatal & Postpartum      Links & Resources

Alcohol Nicotine Marijuana Opiates Benzodiazepines Stimulants Inhalants Hallucinogens & Designer Drugs
Alcohol

Safe Drinking Levels
> No safe threshold for maternal alcohol intake.

> Abstinence is recommended during pregnancy

> Women can be reassured that adverse fetal effects have not been
   demonstrated with mild social drinking before realizing they were pregnant

Screening and Identification
> Ask about number of standard drinks per day and per week.
> 1 standard drink = 1 bottle beer, 5 oz wine, 1 1/2 ounce liquor
> Ask about maximum consumption on any 1 day since pregnancy began.
> Order GGT and MCV if alcohol use suspected (sensitivity 50% for 4 or more
   drinks per day)

T-ACE screening questionnaire

T  Tolerance: How many drinks does it take for you to feel an effect?
A  Have people Annoyed you by criticizing your drinking?
C  Have you felt you ought to Cut down on your drinking?
E  Have you ever had a drink first thing in the morning to steady your nerves or get rid of a hangover?
     (Eye-opener)

Scoring

T: 2 points if it takes more than 2 drinks to make her feel "high"
A,C,E: 1 point for each "yes"
A total of 2 or more points indicates that the woman likely has an alcohol problem (requires further assessment for diagnosis)

Symptoms and Signs of Withdrawal
> Common in women drinking 6 or more drinks per day
> Onset 8-12 hours after last drink, peaks 24-72 hours, may last 7 days
> Tremor (postural, intention), ataxia, sweating are most reliable signs
> Other signs: hypertension, tachycardia, gastrointestinal upset, anxiety
> Complications: seizures (grand-mal, non-focal, brief), hallucinations, arrhythmias, delirium tremens

Management of Withdrawal
> Admit to hospital
> Monitor hydration status and rule out electrolyte imbalance
> Monitor for non-reassuring fetal status
> Folic acid 5mg po od
> Thiamine 100 mg po od x 3 days
> If not in labour, treat with diazepam 20 mg po q 1-2 h until minimal tremor; ongoing treatment not
   usually needed

During labour:

> Notify neonatology/paediatrics: benzodiazepines can cause "floppy baby syndrome"
> Use lorazepam 2-4 mg sl, po q 2-4 h prn

Fetal Effects
Fetal Alcohol Spectrum Disorder (FASD)
   Includes Fetal Alcohol Syndrome and other alcohol-related birth defects and neurological disorders

Prevalence of Fetal Alcohol Spectrum Disorder:
   ~1 in 100 live births

Prevalence of Fetal Alcohol Syndrome:
   ~1 in 1000 live births (general population): 4-5% in heavy drinkers

Features of FAS include:

> Growth restriction
> Characteristic facial anomalies, e.g., microcephaly,micrognathia, short palpebral fissure, flat philtrum
> Central nervous system abnormalities, developmental delays, brain malformations, intellectual
   impairment, behavioural problems
> See guideline on diagnosing FASD in CMAJ 2005; 172 (5suppl.): S1-S21 (www.cmaj.ca)

Other complications of alcohol:

> Spontaneous abortion
> Fetal compromise

Neonatal Effects
> If mother intoxicated at time of delivery, assess neonate for withdrawal

Breastfeeding
> Alcohol enters breast milk and infants are exposed to a fraction of the alcohol ingested by the mother
> Potential adverse effects include: impaired motor development in child and decreased let-down reflex and
   suppressed lactation in mother
> An acceptable level of alcohol in breast milk has not been established
> With moderate, occasional alcohol use: delay nursing for 1-2 hours per drink to minimize infant exposure;
   heavy alcohol consumption while breastfeeding should be avoided while breastfeeding

Management of Alcohol Dependence
> Behavourial interventions recommended
> Pharmacotherapy can help to maintain abstinence e.g., anti-craving (naltrexone and acamprosate) and
   aversive (disulfiram) agents

Anti-alcohol Drugs
> Disulfiram: acetaldehyde dehydrogenase inhibitor;teratogenic, contraindicated in pregnancy

> Naltrexone: opioid receptor antagonist; safety not established in pregnancy; use only if behavioural
                           treatment has failed and benefit outweighs risk

> Acamprosate: glutamate modulator; safety not established in pregnancy, use not recommended
                               in pregnancy
sitemapsearchsite project goalcontact us
©2004-2010 PRIMA. All rights reserved

Production of this report has been made possible through a
financial contribution from the Public Health Agency of Canada

Site last edited: June 2010
The Lawson Foundation